| Authors: |
Leskela S; Institute Ramón y Cajal for Health Research (IRYCIS).; CIBER-ONC, Carlos III Health Institute., Romero I; Clinical Area of Gynecological Oncology., Rosa-Rosa JM; Institute Ramón y Cajal for Health Research (IRYCIS).; CIBER-ONC, Carlos III Health Institute., Caniego-Casas T; Institute Ramón y Cajal for Health Research (IRYCIS).; CIBER-ONC, Carlos III Health Institute., Cristobal E; Institute Ramón y Cajal for Health Research (IRYCIS).; CIBER-ONC, Carlos III Health Institute., Pérez-Mies B; CIBER-ONC, Carlos III Health Institute.; Department of Pathology, Ramón y Cajal University Hospital., Gutierrez-Pecharroman A; Department of Pathology, Ramón y Cajal University Hospital., Santón A; CIBER-ONC, Carlos III Health Institute.; Department of Pathology, Ramón y Cajal University Hospital., Ojeda B; Department of Medical Oncology, Hospital Santa Creu i Sant Pau., López-Reig R; Laboratory of Molecular Biology, Valencian Institute of Oncology., Palacios-Berraquero ML; Department of Hematology and Hemotherapy, Navarra University Clinic, Pamplona., Andrada E; Department of Pathology, Elche University Hospital, Elche., Montes S; Department of Pathology, Marqués de Valdecilla University Hospital, Santander., Pastor F; Department of Pathology, Santa Lucia University Hospital, Murcia, Spain., Gomez MC; Department of Pathology, Germans Trias i Pujol University Hospital, Barcelona., López-Guerrero JA; Laboratory of Molecular Biology, Valencian Institute of Oncology., Poveda A; Oncogynecologic Department, Initia Oncology, Hospital Quironsalud Valencia, Valencia., Palacios J; Institute Ramón y Cajal for Health Research (IRYCIS).; CIBER-ONC, Carlos III Health Institute.; Department of Pathology, Ramón y Cajal University Hospital.; Faculty of Medicine, University of Alcalá de Henares, Madrid. |
